The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality
Aurélie Bannaya b✉, Christophe Chaignotc d, Pierre‐Olivier Blotièrec d e, Mickaël Bassonc d, Alain Weillc d, Philippe Ricordeauc d, François Allac d
- a*Faculté de médecine de Nancy, Université de Lorraine, Vandoeuvre les Nancy †CNAMTS, Paris, France
- bData Science, Knowledge, Reasoning and Engineering - K team (France)
- cCNAMTS, Paris, France
- dFaculté de Médecine [Nancy] (9 avenue de la Forêt de Haye, 54500 Vandoeuvre-les-Nancy - France)
- eAPEMAC - Maladies chroniques, santé perçue, et processus d'adaptation (Université de Lorraine, Faculté de Médecine, 9 avenue de la Forêt de Haye, 54505 Vandoeuvre Les Nancy - France)
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
BACKGROUND: The most used score to measure comorbidity is the Charlson index. Its application to a health care administrative database including International Classification of Diseases, 10th edition (ICD-10) codes, medical procedures, and medication required studying its properties on survival. Our objectives were to adapt the Charlson comorbidity index to the French National Health Insurance database to predict 1-year mortality of discharged patients and to compare discrimination and calibration of different versions of the Charlson index. METHODS: Our cohort included all adults discharged from a hospital stay in France in 2010 registered in the French National Health Insurance general scheme. The pathologies of the Charlson index were identified through ICD-10 codes of discharge diagnoses and long-term disease, specific medical procedures, and reimbursement of specific medications in the past 12 months before inclusion. RESULTS: We included 6,602,641 subjects at the date of their first discharge from medical, surgical, or obstetrical department in 2010. One-year survival was 94.88%, decreasing from 98.41% for Charlson index of 0-71.64% for Charlson index of ≥5. With a discrimination of 0.91 and an appropriate calibration curve, we retained the crude Cox model including the age-adjusted Charlson index as a 4-level score. CONCLUSIONS: Our study is the first to adapt the Charlson index to a large health care database including >6 million of inpatients. When mortality is the outcome, we recommended using the age-adjusted Charlson index as 4-level score to take into account comorbidities.
TL;DRThis study is the first to adapt the Charlson index to a large health care database including >6 million of inpatients and recommended using the age-adjusted Charlson Index as 4-level score to take into account comorbidities. (Semantic Scholar)

